Home/Filings/4/0001209191-23-015879
4//SEC Filing

Gaspar Bobby 4

Accession 0001209191-23-015879

CIK 0001748907other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:00 PM ET

Size

7.9 KB

Accession

0001209191-23-015879

Insider Transaction Report

Form 4
Period: 2023-03-01
Gaspar Bobby
DirectorSee Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-01+563,410563,410 total
    Exercise: $0.46Exp: 2033-02-28Ordinary Shares (563,410 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-03-01+581,590581,590 total
    Exercise: $0.58Exp: 2033-02-28Ordinary Shares (581,590 underlying)
Footnotes (2)
  • [F1]The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2023.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

Orchard Therapeutics plc

CIK 0001748907

Entity typeother

Related Parties

1
  • filerCIK 0001793992

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:00 PM ET
Size
7.9 KB